USD 5.6 billion
Macrolide Antibiotics Market Size, Share, Growth Analysis, By Drug Type(Azithromycin, Erythromycin, and Others), By Route of Administration(Oral, Parenteral and Others), By Distribution Channel(Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35I2327 |
Region:
Global |
Published Date: April, 2024
Pages:
218
|Tables:
89
|Figures:
71
Macrolide Antibiotics Market Insights
Global Macrolide Antibiotics Market size was valued at USD 5.6 billion in 2022, USD 5.73 billion in 2023 and is projected to grow USD 6.72 billion by 2031, growing at a CAGR of 2.3% in the forecast period (2024-2031).
Antibiotics belonging to the macrolide class have a macrocyclic lactone structure with one or more deoxy sugars attached. The macrolides bind irreversibly to a region on the 50S subunit of the bacterial ribosome to impede the translocation phases of protein synthesis. Even though they are usually thought of as bacteriostatic medications, larger dosages may have bactericidal effects. These macrolide antibiotics are used to treat sexually transmitted infections including gonorrhea and chlamydia and respiratory tract infections like pneumonia, bronchitis, sinusitis, and pharyngitis.
Globally rising infectious illness rates are the main factor fueling the market's expansion. The National Centre for Biotechnology Information (NCBI) estimates that between 1.5 and 14 instances of community-acquired pneumonia per 1000 people occur worldwide each year. Furthermore, there are 24.8 cases per 10,000 people in the United States each year, and the prevalence rises with age. The need for macrolide antibiotics as a treatment for community-acquired pneumonia is rising in the United States and other nations. This increases the market share of macrolide antibiotics. The market is growing as generic antibiotics are now more widely available. The goal of many market participants is to create generic equivalents of name-brand macrolide antibiotics.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Azithromycin
Fastest Growth
Erythromycin
Growth Rate
2.3% CAGR
Global Macrolide Antibiotics Market ($ Bn)
Country Share by North America (%)
To get more reports on the above market click here to Buy The Report
Macrolide Antibiotics Market Segmental Analysis
The global macrolide antibiotics market is segmented based on drug type, route, distribution channel and regional type. In terms of drug type, the market is segmented into azithromycin, erythromycin and others. Based on route of administration, the market is bifurcated into oral, parenteral and others. Based on distribution channel, the market is bifurcated into hospital pharmacies, drug stores & retail pharmacies and online providers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. The product segment's potential to improve patient outcomes and lessen the cost of healthcare is what will drive its future growth.
Analysis by Drug Type
As per categorization by drug type, the market is classified into azithromycin, erythromycin and others. Among these, azithromycin earned the largest share and continues to dominate the market. As azithromycin works against a wide range of bacterial infections, including respiratory and STDs, the worldwide macrolide antibiotics industry is still seeing innovation and rising azithromycin usage. Due in part to azithromycin's efficiency, easy to follow dosage instructions, and comparatively low rate of side effects, it is widely used. Furthermore, continuing research and development initiatives seek to investigate novel formulations and indications, thereby strengthening azithromycin's standing in the international market.
Erythromycin is leading the charge in the rapidly expanding worldwide macrolide antibiotic market. Its extensive application in treating a variety of diseases, such as skin and respiratory conditions, together with its potency against a wide range of bacteria, establish it as a mainstay drug. Its potential for market expansion is also increased by the growing incidence of bacterial illnesses around the globe as well as the creation of innovative formulations and delivery systems. Erythromycin is the fastest-growing competitor in the worldwide macrolide antibiotics market due to its proven effectiveness and flexibility to meet changing medical needs.
Analysis by Distribution Channel
Leading the way in innovation and consumption patterns within the global market for macrolide antibiotics are hospital pharmacies. The role of hospital pharmacy in encouraging rational antibiotic usage and implementing recommendations for safe prescribing is vital, especially with the growing emphasis on antimicrobial stewardship programmes within healthcare facilities. They also act as centers of research and development, encouraging the creation of new macrolide antibiotic formulations and delivery systems that improve their effectiveness and address new patterns of resistance.
Due to their accessibility and convenience, drug shops, retail pharmacies, and internet suppliers are expected to develop at the fastest rate in the global market for macrolide antibiotics. Customers are turning more to telemedicine and self-care in healthcare to get fast access to antibiotics, especially macrolides, for common diseases. In addition, the growing market penetration of internet pharmacies allows them to serve a worldwide clientele. Sales of macrolide antibiotics have significantly increased because of this move towards retail and internet channels, which highlights how the healthcare delivery system is changing.
Global Macrolide Antibiotics Market By Drug Type (%)
To get detailed analysis on other segments, Request For Free Sample Report
Macrolide Antibiotics Market Regional Insights
In 2022, the Macrolide Antibiotics Market in North America held a 45.80% market share. The region's high demand for and use of antibiotics, especially macrolides, is one of the causes of this. In addition, the Macrolide Antibiotics market in the United States had the biggest market share, while the Armour Materials market in Canada had the quickest rate of growth in the North American area. The market share of macrolide antibiotics in Europe is the second greatest. This is because as infectious diseases become more common, there is an increasing need for antibiotics. Additionally, the Macrolide Antibiotics market in Germany had the most market share, while the Macrolide Antibiotics market in the UK had the highest rate of growth in the European Union.
From 2023 to 2032, the Macrolide Antibiotics Market in Asia-Pacific is predicted to develop at the quickest compound annual growth rate (CAGR). the expansion of healthcare spending and the dissemination of information about these therapies' accessibility. Furthermore, it is anticipated that the favorable reimbursement policies in Japan will boost the country's macrolide antibiotic sales. Furthermore, the Macrolide Antibiotics market in China commanded the most market share, while the Macrolide Antibiotics market in India grew at the fastest rate in the Asia-Pacific area. Despite its potential for expansion, Latin America continues to lag due to its economic conditions. The Middle East and Africa have a reduced market share, mostly as poorer healthcare access and scarce resources for the distribution and acquisition of antibiotics. Asia Pacific is showing a lot of growth prospects, North America and Europe are still the leading participants overall.
Global Macrolide Antibiotics Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Macrolide Antibiotics Market Dynamics
Drivers
Emerging Trends for Macrolide Antibiotics Market
- China, India, Brazil, and other developing nations are examples of emerging markets that present the macrolide antibiotics industry with substantial growth potential. The need for antibiotics is higher in these areas due to their huge populations and rising healthcare costs. Additionally, producers of macrolide antibiotics have opportunity to increase their footprint and capitalise on these expanding markets due to the increased incidence of bacterial illnesses and the demand for efficient treatment alternatives in these areas.
Therapeutic Developments
- The development of novel macrolide antibiotics is made possible by ongoing research and development efforts in the field of antibiotics. The quest for novel treatment alternatives and the rise of drug-resistant bacteria are driving efforts to discover new macrolide compounds with improved efficacy and decreased resistance. Creating macrolides with enhanced pharmacokinetic profiles, a wider range of action, and fewer side effects can give businesses a competitive edge and create new market niches.
Restraints
Macrolide Antibiotic Resistance
- The market is severely challenged by the rise and spread of microorganisms resistant to antibiotics. Resistance to antibiotics, particularly macrolides, is a result of both overuse and misuse. This may decrease the long-term market potential of macrolide antibiotics and their ability to treat bacterial infections. To combat the growing problem of antibiotic-resistant bacteria, new medications and other therapeutic approaches must be developed.
General Safety and Side effects Conce
- Despite their typically good toleration, macrolide antibiotics can nevertheless cause side effects and raise safety issues. Gastrointestinal disorders, such as nausea, vomiting, and diarrhoea, are frequent adverse effects. Rarely, more severe side effects such allergic responses, liver damage, and heart arrhythmias might occur. These safety issues may affect patient adherence, restrict the use of macrolides in specific patient groups, and maybe bring regulatory attention. Ensuring the appropriate and safe use of macrolide antibiotics is a continuous problem for healthcare practitioners and manufacturers.
Request Free Customization of this report to help us to meet your business objectives.
Macrolide Antibiotics Market Competitive Landscape
Prominent industry participants are making significant investments in R&D to broaden their product offerings, hence contributing to the Macrolide Antibiotics market's continued expansion. To increase their worldwide presence, market players are also engaging in a range of strategic initiatives. Notable changes in the industry include the introduction of new products, contracts, mergers and acquisitions, increased investment, and cooperation with other businesses. This enormous healthcare facility provides state-of-the-art medical care. Outside of North America and Canada, Merck Sharp & Dohme Corp. is also known as MSD. This is one of the largest pharmaceutical companies in the world. Merck Sharp & Dohme Corp. is a business that discovers, manufactures, and distributes medications, vaccines, and medical supplies for both people and animals.
Top Player’s Company Profiles
- Boehringer Ingelheim International Gmbh (Germany)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Bayer AG (Germany)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Barkat Pharmaceutical Group (Iran)
- Bristol-Myers Squibb Company (US)
- Pfizer Inc. (US)
- Sandoz International GmbH (Germany)
- Merck & Co., Inc. (US)
- Zhejiang Guobang Pharmaceutical Co., Ltd. (China)
- Novartis AG (Switzerland)
- Sanofi (France)
- Astrazeneca (UK)
- Sanofi (France)
- Abbott (US)
Recent Developments
- In April 2022, Teva Pharmaceutical Industries Ltd. expanded its line of economical treatment alternatives for bacterial infections by launching a generic version of the popular macrolide antibiotic clarithromycin. This action supports Teva's objective to address the growing need for effective antibiotics while guaranteeing their accessibility and affordability for patients everywhere, hence fostering the company's expansion in the global market for macrolide antibiotics.
- In July 2022, the discovery of a next-generation macrolide antibiotic with increased potency against microorganisms resistant to several drugs was disclosed by Novartis AG. By providing cutting-edge treatment options for difficult infections, Novartis hopes to combat the growing danger of antibiotic resistance and strengthen its position in the global macrolide antibiotics market. It does this by utilizing cutting-edge drug development technology.
- In October 2023, Phase 3 clinical trials for a novel extended-release version of azithromycin have been disclosed by Pfizer Inc. with the goal of improving patient compliance and dosage convenience while treating bacterial infections. This breakthrough demonstrates Pfizer's dedication to developing macrolide antibiotic treatments to meet changing healthcare demands and fight antibiotic resistance worldwide.
Macrolide Antibiotics Key Market Trends
- Addressing Bacterial Resistance: As the pharmaceutical industry continues to innovate and tackle bacterial illnesses with a focus on safety and efficacy, the market for macrolide antibiotics is witnessing major trends. An important development in the industry is the rising need for new macrolide derivatives and formulations. To improve pharmacokinetics, increase the range of activity, and combat bacterial resistance, scientists and pharmaceutical corporations are investigating changes to the current class of macrolide antibiotics. This pattern shows a dedication to keeping up with changing microbial dangers and maximizing available treatments for a wide variety of illnesses.
- Advancement in Treatment Strategies: The emphasis on combination therapy is another significant trend in the market for macrolide antibiotics. To produce synergistic effects and fight bacterial infections more successfully, macrolides are frequently used in combination with other antibiotics. Combination medicines can improve bacterial coverage and lower resistance development in the treatment of sexually transmitted infections and respiratory tract infections. The market is also seeing a significant increase in the creation of antibiotics known as long-acting macrolides.
Macrolide Antibiotics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, due to their sizable populations and rising healthcare demands, developing countries like China, India, and Brazil present the macrolide antibiotics market with substantial growth potential. By responding to the expanding need for effective treatment alternatives in the face of an increase in bacterial infections, producers can increase their market share in these areas. The market for macrolide antibiotics is facing a major challenge from the emergence of bacteria that are resistant to these medications due to their overuse and misuse. The development of new drugs and treatment strategies is required since this resistance jeopardizes their long-term efficacy in treating bacterial infections. Healthcare professionals and manufacturers are nevertheless faced with the constant struggle of addressing these safety problems.
Leading players in the market are putting a lot of money into research and development to diversify their product lines, which is propelling the Macrolide Antibiotics market's steady expansion. They are also utilizing several strategic measures to fortify their position globally, such as new product launches, agreements, mergers and acquisitions, higher investment levels, and joint ventures with other businesses, all of which highlight Merck Sharp & Dohme Corp.'s important position as one of the biggest pharmaceutical companies in the world, offering state-of-the-art medical solutions. Major trends in the macrolide antibiotics market are driven by the pharmaceutical industry's focus on innovation and efficacy in treating bacterial infections. One such trend is the rising demand for new derivatives and formulations to improve pharmacokinetics, broaden activity, and fight resistance, demonstrating a dedication to adapting to changing microbial threats.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 5.6 billion |
| Market size value in 2031 | USD 6.72 billion |
| Growth Rate | 2.3% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Macrolide Antibiotics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Macrolide Antibiotics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Macrolide Antibiotics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Macrolide Antibiotics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Macrolide Antibiotics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Macrolide Antibiotics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
